Agilent Technologies, Inc. (FRA:AG8)
Germany flag Germany · Delayed Price · Currency is EUR
102.50
-1.08 (-1.04%)
Last updated: Jul 4, 2025

Revenue by Product

Fiscal year is November - October.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2012 - 2019
Life Sciences & Applied Markets
3.22B
Log In
Log In
Log In
Log In
Upgrade
Life Sciences & Applied Markets Growth
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics
1.65B
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Revenue (Pre-FY2025 Reporting)
1.64B
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Revenue (Pre-FY2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade

EBIT by Product

Fiscal year is November - October.
Fiscal Year
FY 2024 FY 2023 FY 2022 FY 2021 FY 2020 2012 - 2019
Period Ending
Oct '24 Oct '23 Oct '22 Oct '21 Oct '20 2012 - 2019
Other
-177.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Life Sciences & Applied Markets Income from Operations
877.00M
Log In
Log In
Log In
Log In
Upgrade
Life Sciences & Applied Markets Income from Operations Growth
-
Log In
Log In
Log In
Log In
Upgrade
Other
-177.00M
Log In
Log In
Log In
Log In
Upgrade
Other Growth
-
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics Income from Operations
320.00M
Log In
Log In
Log In
Log In
Upgrade
Diagnostics & Genomics Income from Operations Growth
-
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Income from Operations (Pre-FY2025 Reporting)
524.00M
Log In
Log In
Log In
Log In
Upgrade
Agilent CrossLab Income from Operations (Pre-FY2025 Reporting) Growth
-
Log In
Log In
Log In
Log In
Upgrade